Bicara Therapeutics Inc. Common Stock
USD27.94
+0.79 (+2.91%)
CEO
Claire Mazumdar Clemon
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.18
Prev. Close
$27.15
Day Low
$26.68
Day High
$28.09
52W Low
$9.57
52W High
$30.99
Market Cap
$1.53B
Volume
0.10M
| 9,972 |
| $28.42 |
| 14 Jul 2026 | Mazumdar Claire | director, officer: Chief Executive Officer | S-Sale | Disposed | 28 | $29.68 |
| 14 Jul 2026 | Mazumdar Claire | director, officer: Chief Executive Officer | M-Exempt | Disposed | 10,000 | $3.79 |
| 10 Jul 2026 | Cohlhepp Ryan | director, officer: President and COO | M-Exempt | Acquired | 18,750 | $3.79 |
| 10 Jul 2026 | Cohlhepp Ryan | director, officer: President and COO | S-Sale | Disposed | 22,833 | $28.76 |
| 10 Jul 2026 | Cohlhepp Ryan | director, officer: President and COO | S-Sale | Disposed | 4,306 | $29.80 |
| 10 Jul 2026 | Cohlhepp Ryan | director, officer: President and COO | S-Sale | Disposed | 1,075 | $30.35 |
| 10 Jul 2026 | Cohlhepp Ryan | director, officer: President and COO | S-Sale | Disposed | 536 | $29.00 |
| 10 Jul 2026 | Cohlhepp Ryan | director, officer: President and COO | M-Exempt | Disposed | 18,750 | $3.79 |